)
Ning Wang
Founder & CEO,
Decode Origin
Dr. Ning Wang is CEO and Founder of Decode Origin, bringing deep bioinformatics expertise to technology entrepreneurship. With a background spanning computational biology and drug development, he has experience in advancing clinical programs.
Dr. Wang has led biomarker analysis across multiple oncology clinical trials, including the Quemliclustat and Etrumadenant programs. He initiated clinical genomics real-world data efforts to accelerate drug development and generated bioinformatics data packages for clinical trials of novel therapeutics including the AXL inhibitor AB801. Dr. Wang has filed patents on predictive biomarkers.
Sessions